Methylphenidate is not licensed for the initiation of treatment for ADHD in adults. Concerta XL ® is the only methylphenidate preparation which is licensed as continuation treatment; for patients ...
Cingulate Inc. (NASDAQ:CING) announced the successful completion of its final FDA-required study for CTx-1301 (dexmethylphenidate) aimed at treating Attention Deficit Hyperactivity Disorder (ADHD).
Adults with attention-deficit/hyperactivity disorder (ADHD) are more frequently presenting for diagnosis and treatment. Medication is considered to be appropriate ...